Baxter International (BAX) Cost of Revenue (2016 - 2024)
Historic Cost of Revenue for Baxter International (BAX) over the last 16 years, with Q4 2024 value amounting to $1.8 billion.
- Baxter International's Cost of Revenue rose 24765.43% to $1.8 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $7.3 billion, marking a year-over-year increase of 1800.32%. This contributed to the annual value of $7.9 billion for FY2025, which is 1823.51% up from last year.
- According to the latest figures from Q4 2024, Baxter International's Cost of Revenue is $1.8 billion, which was up 24765.43% from $1.7 billion recorded in Q3 2024.
- Over the past 5 years, Baxter International's Cost of Revenue peaked at $2.6 billion during Q2 2023, and registered a low of -$1.2 billion during Q4 2023.
- For the 5-year period, Baxter International's Cost of Revenue averaged around $1.7 billion, with its median value being $1.9 billion (2021).
- As far as peak fluctuations go, Baxter International's Cost of Revenue crashed by 13099.73% in 2022, and later soared by 24765.43% in 2024.
- Baxter International's Cost of Revenue (Quarter) stood at $2.0 billion in 2020, then fell by 6.78% to $1.9 billion in 2021, then plummeted by 131.0% to -$575.0 million in 2022, then crashed by 111.3% to -$1.2 billion in 2023, then skyrocketed by 247.65% to $1.8 billion in 2024.
- Its last three reported values are $1.8 billion in Q4 2024, $1.7 billion for Q3 2024, and $1.7 billion during Q2 2024.